Leg Heat Therapy for Peripheral Arterial Disease
Trial Summary
What is the purpose of this trial?
The goal of this randomized, double-blind, sham-controlled clinical trial is to evaluate the benefits of home-based, leg heat therapy (HT) on lower-extremity functioning and quality of life in patients who suffer from lower-extremity peripheral artery disease (PAD). We will randomize 106 patients to one of two groups that either receive leg HT or a sham intervention. The primary study outcome is the change in 6-minute walk distance between baseline and the 12-week follow up. Secondary outcomes include changes in the short physical performance battery score, handgrip strength, quality of life (measured by the Walking Impairment Questionnaire and Short-Form (SF)-36 Questionnaire), calf muscle strength (measured using a calf ergometer), size (measured by magnetic resonance imaging) and bioenergetics (assessed using phosphorus-31 magnetic resonance spectroscopy), and physical activity (measured by accelerometer).
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of leg heat therapy for peripheral arterial disease?
Is leg heat therapy safe for humans?
How does leg heat therapy differ from other treatments for peripheral arterial disease?
Leg heat therapy is unique because it involves using warm water to increase blood flow and reduce blood pressure, which can improve walking performance in patients with peripheral arterial disease. Unlike traditional exercise therapy, it can be done at home, is painless, and may be easier for patients to adhere to, especially those who experience pain during exercise.12345
Eligibility Criteria
This trial is for men and women over 60 with lower-extremity peripheral artery disease (PAD), evidenced by a low ankle-brachial index. It's not for those with critical limb ischemia, other conditions limiting exercise tolerance, recent leg surgeries, use of walking aids besides a cane, severe kidney disease or obesity, inability to wear water-circulating trousers, certain mental impairments or thermal sensation issues in the legs.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive daily leg heat therapy or sham treatment for 90 minutes over 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Leg Heat Therapy
- Sham Control
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
Purdue University
Collaborator
National Institute on Aging (NIA)
Collaborator